Could GLP-1 Drugs Protect Your Joints and Bones?

GLP-1 receptor agonists, medications like semaglutide, liraglutide, exenatide, dulaglutide, and lixisenatide, are best known for treating type 2 diabetes and supporting weight loss. But researchers are now exploring something unexpected: could these same drugs also help protect joints in osteoarthritis and strengthen bones in osteoporosis? A 2025 review in Medicine examined how GLP-1 receptor agonists might affect both conditions. The idea is exciting because osteoarthritis and osteoporosis often occur together in older adults, and currently, no single medication effectively treats both.